Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calin

Showing results (261-270 of 747) with videos related to

Pageof 75
Sort By:
Cells|January 11, 2024
miR-142: A Master Regulator in Hematological Malignancies and Therapeutic OpportunitiesWilson Huang, Doru Paul, George A Calin, et al.
Nature Reviews. Genetics|November 15, 2023
Non-coding RNAs in disease: from mechanisms to therapeuticsKinga Nemeth, Recep Bayraktar, Manuela Ferracin, et al.
Nature Reviews. Clinical Oncology|May 23, 2018
Clinical utility of circulating non-coding RNAs - an updateSimone Anfossi, Anna Babayan, Klaus Pantel, et al.
Cancer Biology & Therapy|February 9, 2010
MicroRNAs and metastases--the neuroblastoma linkMaria I Almeida, Rui M Reis, George A Calin
Mathematical Biosciences|August 8, 2016
From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localizationCatalin Vasilescu, Mihai Tanase, Mihnea Dragomir, et al.
Seminars in Hematology|May 9, 2024
miRNA Biology in Chronic Lymphocytic LeukemiaRecep Bayraktar, Beatrice Fontana, George A Calin, et al.
Frontiers in Medicine|December 24, 2015
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?Cristina Sorina Cătană, George A Calin, Ioana Berindan-Neagoe
Cancers|August 12, 2022
miRacle of microRNA-Driven Cancer NanotherapeuticsGoknur Kara, Banu Arun, George A Calin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2022
At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targetsA Jurj, D Qian, G A Calin, et al.
Cancer Biology & Medicine|June 29, 2018
Key questions about the checkpoint blockade-are microRNAs an answer?Mihnea Dragomir, Baoqing Chen, Xiao Fu, et al.
Pageof 75

Showing results (261-270 of 747) with videos related to

Sort By:
Pageof 75
Cells|January 11, 2024
miR-142: A Master Regulator in Hematological Malignancies and Therapeutic OpportunitiesWilson Huang, Doru Paul, George A Calin, et al.
Nature Reviews. Genetics|November 15, 2023
Non-coding RNAs in disease: from mechanisms to therapeuticsKinga Nemeth, Recep Bayraktar, Manuela Ferracin, et al.
Nature Reviews. Clinical Oncology|May 23, 2018
Clinical utility of circulating non-coding RNAs - an updateSimone Anfossi, Anna Babayan, Klaus Pantel, et al.
Cancer Biology & Therapy|February 9, 2010
MicroRNAs and metastases--the neuroblastoma linkMaria I Almeida, Rui M Reis, George A Calin
Mathematical Biosciences|August 8, 2016
From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localizationCatalin Vasilescu, Mihai Tanase, Mihnea Dragomir, et al.
Seminars in Hematology|May 9, 2024
miRNA Biology in Chronic Lymphocytic LeukemiaRecep Bayraktar, Beatrice Fontana, George A Calin, et al.
Frontiers in Medicine|December 24, 2015
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?Cristina Sorina Cătană, George A Calin, Ioana Berindan-Neagoe
Cancers|August 12, 2022
miRacle of microRNA-Driven Cancer NanotherapeuticsGoknur Kara, Banu Arun, George A Calin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2022
At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targetsA Jurj, D Qian, G A Calin, et al.
Cancer Biology & Medicine|June 29, 2018
Key questions about the checkpoint blockade-are microRNAs an answer?Mihnea Dragomir, Baoqing Chen, Xiao Fu, et al.
Pageof 75